The naturally occurring MBD4 truncation at amino acid 313 in MMR‐deficient human carcinomas presumably has the potential to affect the protein interaction profile of MBD4 in addition to losing the catalytically active C‐terminal glycosylase domain (Fig. 2A, black arrow). This evidence concerns the gene MBD4 and carcinoma.